Announcement of the resolution of the first extraordinary Shareholders' Meeting in 2024.
Legal opinion of Kangda (Guangzhou) Law Firm on Star Lake Bioscience's First Extraordinary General Meeting of Shareholders in 2024 in Peking.
Materials for the first ad-hoc shareholders' meeting in 2024.
Notice of the First Extraordinary Shareholders' Meeting in 2024
Announcement regarding the subsidiary's application for project loan from banks and guaranteed by the company.
Announcement on holding a briefing session on the results and cash dividends for the first quarter of 2023 and 2024
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
2023 Annual General Meeting of Shareholders Legal Opinions
Reply to the inquiry letter from Xinghu Technology
Reply to the inquiry letter from Xinghu Technology
Reply to the inquiry letter from Xinghu Technology
2023 Annual General Meeting of Shareholders Meeting Materials
Reply to the inquiry letter from Xinghu Technology
Reply to the inquiry letter from Xinghu Technology
Non-operating capital occupation and other related capital transactions
2023 Internal Control Evaluation Report
Report on the performance of the Audit Committee of the Board of Directors in 2023
Report on the performance of the Audit Committee of the Board of Directors in 2023
Special meeting system for independent directors (established in 2024)
Announcement on the holding subsidiary carrying out financial derivatives trading business
No Data